DIFFUSE LARGE B-CELL LYMPHOMA STAGE I

This adverse event was reported 42 times

These drugs are most commonly taken by patients reporting DIFFUSE LARGE B-CELL LYMPHOMA STAGE I:

# Drug Count
0 PREDNISOLONE 10
1 PREDNISOLONE ORAL 10
2 PREDNISOLONE ORAL SOLUTION 10
3 METHOTREXATE SODIUM 9
4 METHOTREXATE 8
5 AZATHIOPRINE 7
6 PREDNISONE 6
7 ADALIMUMAB 5
8 CYCLOSPORINE 5
9 TACROLIMUS 5
See all common drugs associated with DIFFUSE LARGE B-CELL LYMPHOMA STAGE I

DIFFUSE LARGE B-CELL LYMPHOMA STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZALEPLON 1 0.0006
1 SILVER SULFADIAZINE 1 0.0004
2 BARICITINIB 1 0.0003
3 PHENAZOPYRIDINE 1 0.0003
4 SIROLIMUS 2 0.0001
5 DACARBAZINE 1 0.0001
6 BLEOMYCIN SULFATE 1 0.0001
7 AZATHIOPRINE 7 0.0001
8 TELMISARTAN 1 0.0001
9 PREDNISOLONE ORAL SOLUTION 10 0.0001
See all drugs enriched for association with DIFFUSE LARGE B-CELL LYMPHOMA STAGE I